AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

American Medical Technologies Inc.

$0 +$0.00 (+0.00%)
OTC · 11 Sep 2026 20:00 UTC
Previous Close
$0
Day Range
$0$0
Year Range
$0$0
Market Cap
1.03K
AVG Volume
228
Trailing/Forward PE
-0/-
PEG ratio
-0
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Other OTCUS
Revenue (USD)
0250K500K750K1M06 Q206 Q306 Q407 Q107 Q207 Q307 Q408 Q108 Q208 Q3
ADLI Revenue (USD) by quarter
PeriodRevenue (USD)
08 Q3594.91K
08 Q2696.77K
08 Q1639.91K
07 Q4709.95K
07 Q3792.87K
07 Q2827.47K
07 Q1861.18K
06 Q4892.86K
06 Q3775.99K
06 Q2622.9K
Net Income (USD)
-750K-500K-250K0250K06 Q206 Q306 Q407 Q107 Q207 Q307 Q408 Q108 Q208 Q3
ADLI Net Income (USD) by quarter
PeriodNet Income (USD)
08 Q3-117.16K
08 Q2169.4K
08 Q14.59K
07 Q4137.19K
07 Q3-316.42K
07 Q2-54.95K
07 Q1-692.72K
06 Q46K
06 Q3-176.34K
06 Q2-275.33K
Operating Income (USD)
0200K400K600K06 Q206 Q306 Q407 Q107 Q207 Q307 Q408 Q108 Q208 Q3
ADLI Operating Income (USD) by quarter
PeriodOperating Income (USD)
08 Q389.78K
08 Q254.31K
08 Q1190.86K
07 Q4144.39K
07 Q3555.9K
07 Q2198.18K
07 Q1265.75K
06 Q4247.67K
06 Q3226.75K
06 Q2278.23K
EBITDA (USD)
-600K-400K-200K006 Q206 Q306 Q407 Q107 Q207 Q307 Q408 Q108 Q208 Q3
ADLI EBITDA (USD) by quarter
PeriodEBITDA (USD)
08 Q3-43.5K
08 Q2-3.06K
08 Q1-139.07K
07 Q4-92.39K
07 Q3-502.65K
07 Q2-143.81K
07 Q1-225.09K
06 Q4-138.62K
06 Q3-202.28K
06 Q2-278.23K
Cash Flows (USD)
-1.5M-1M-500K0500K06 Q206 Q306 Q407 Q107 Q207 Q307 Q408 Q108 Q208 Q3
ADLI Cash Flows (USD) by quarter
PeriodCash Flows (USD)
08 Q3-37.85K
08 Q233.96K
08 Q1-90.94K
07 Q4-116.6K
07 Q3-68.48K
07 Q2-58.86K
07 Q1-143.66K
06 Q4-253.06K
06 Q3-12.38K
06 Q2-1.09M
EPS (USD)
-0.1-0.0500.0506 Q206 Q306 Q407 Q107 Q207 Q307 Q408 Q108 Q208 Q3
ADLI EPS (USD) by quarter
PeriodEPS (USD)
08 Q3-0.01
08 Q20.02
08 Q10
07 Q40.02
07 Q3-0.04
07 Q2-0.01
07 Q1-0.08
06 Q40
06 Q3-0.02
06 Q2-0.03
Expenses (USD)
0250K500K750K1MR&DSG&ACapex06 Q206 Q306 Q407 Q107 Q207 Q307 Q408 Q108 Q208 Q3
ADLI Expenses (USD) by quarter
PeriodExpenses (USD)
08 Q3468.57K
08 Q2527.35K
08 Q1638.36K
07 Q4539.59K
07 Q3810.41K
07 Q2720.74K
07 Q1822.79K
06 Q4785.45K
06 Q3638.6K
06 Q2630.49K
Cash & Debt (USD)
0500K1M1.5MCashLong Term DebtShort Term Debt06 Q206 Q306 Q407 Q107 Q207 Q307 Q408 Q108 Q208 Q3
ADLI Cash & Debt (USD) by quarter
PeriodCash & Debt (USD)
08 Q3374.85K
08 Q2414.66K
08 Q1335.46K
07 Q4334.32K
07 Q3435.88K
07 Q2548.58K
07 Q1601.74K
06 Q4549.9K
06 Q31.04M
06 Q2897.68K
Debt ratios
-2-1.5-1-0.500.506 Q206 Q306 Q407 Q107 Q207 Q307 Q408 Q108 Q208 Q3
ADLI Debt ratios by quarter
PeriodDebt ratios
08 Q3-1.55
08 Q2-0.6
08 Q1-0.29
07 Q4-0.17
07 Q3-0.08
07 Q20.04
07 Q10.1
06 Q40.1
06 Q30.21
06 Q2-0.08
Margins
0%20%40%60%80%06 Q206 Q306 Q407 Q107 Q207 Q307 Q408 Q108 Q208 Q3
ADLI Margins by quarter
PeriodMargins
08 Q363.67%
08 Q267.41%
08 Q169.76%
07 Q453.88%
07 Q331.69%
07 Q262%
07 Q164.13%
06 Q458.41%
06 Q352.07%
06 Q256.55%
Return on Capital
-100%-50%0%50%06 Q206 Q306 Q407 Q107 Q207 Q307 Q408 Q108 Q208 Q3
ADLI Return on Capital by quarter
PeriodReturn on Capital
08 Q332.3%
08 Q2-66.02%
08 Q1-0.99%
07 Q4-26.81%
07 Q340.57%
07 Q25.39%
07 Q145.9%
06 Q4-0.7%
06 Q320.69%
06 Q240.42%
Shares Outstanding
05M10M15M06 Q206 Q306 Q407 Q107 Q207 Q307 Q408 Q108 Q208 Q3
ADLI Shares Outstanding by quarter
PeriodShares Outstanding
08 Q310.39M
08 Q210.29M
08 Q110.17M
07 Q49.89M
07 Q38.45M
07 Q28.19M
07 Q18.19M
06 Q48.19M
06 Q38.19M
06 Q29.18M
Book Value Per Share (USD)
-0.2-0.15-0.1-0.05-006 Q206 Q306 Q407 Q107 Q207 Q307 Q408 Q108 Q208 Q3
ADLI Book Value Per Share (USD) by quarter
PeriodBook Value Per Share (USD)
08 Q3-0.03
08 Q2-0.02
08 Q1-0.05
07 Q4-0.05
07 Q3-0.09
07 Q2-0.12
07 Q1-0.18
06 Q4-0.1
06 Q3-0.1
06 Q2-0.07
Total Assets (USD)
01M2M3M06 Q206 Q306 Q407 Q107 Q207 Q307 Q408 Q108 Q208 Q3
ADLI Total Assets (USD) by quarter
PeriodTotal Assets (USD)
08 Q31.58M
08 Q21.81M
08 Q11.79M
07 Q41.84M
07 Q32.03M
07 Q22.56M
07 Q12.17M
06 Q42.06M
06 Q32.11M
06 Q22.65M
PE Ratio
00.250.50.7511.25med 0.01Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
ADLI PE Ratio by quarter
PeriodPE Ratio
Sep 260.01
Sep 260.01
Aug 260.01
Aug 260.01
Aug 260.01
Aug 260.01
Jul 260.01
Jul 260.01
Jul 260.01
Jul 260.01
Jul 260.01
Jun 260.01
Jun 260.01
Jun 260.01
Jun 260.01
May 260.01
May 260.01
May 260.01
May 260.01
May 260.01
Apr 260.01
Apr 260.01
Apr 260.01
Apr 260.01
Mar 260.01
Mar 260.01
Mar 260.01
Mar 260.01
Feb 260.01
Feb 260.01
Feb 260.01
Feb 260.01
Jan 260.01
Jan 260.01
Jan 260.01
Jan 260.01
Jan 260.01
Dec 250.01
Dec 250.01
Dec 250.01
Dec 250.01
Nov 250.01
Nov 250.01
Nov 250.01
Nov 250.01
Oct 250.01
Oct 250.01
Oct 250.01
Oct 250.01
Oct 250.01
Sep 250.01
Sep 250.01
Sep 250.01
Sep 250.01
Aug 250.01
Aug 250.01
Aug 250.01
Aug 250.01
Aug 250.01
Jul 250.01
Jul 250.01
Jul 250.01
Jul 250.01
Jun 250.01
Jun 250.01
Jun 250.01
Jun 250.01
May 250.01
May 250.01
May 250.01
May 250.01
May 250.01
Apr 250.01
Apr 250.01
Apr 250.01
Apr 250.01
Mar 250.01
Mar 250.01
Mar 250.01
Mar 250.01
Feb 250.01
Feb 250.01
Feb 250.01
Feb 250.01
Jan 250.01
Jan 250.01
Jan 250.01
Jan 250.01
Jan 250.01
Dec 240.01
Dec 240.01
Dec 240.01
Dec 240.01
Nov 240.01
Nov 240.01
Nov 240.01
Nov 240.01
Nov 240.01
Oct 240.01
Oct 240.01
Free Cash Flow Yield
-20351.75%-20351.5%-20351.25%-20351%-20350.75%-20350.5%med -20351.7%Jan 25May 25Sep 25Jan 26May 26Sep 26
ADLI Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-20351.7%
Sep 26-20351.7%
Aug 26-20351.7%
Aug 26-20351.7%
Aug 26-20351.7%
Aug 26-20351.7%
Jul 26-20351.7%
Jul 26-20351.7%
Jul 26-20351.7%
Jul 26-20351.7%
Jul 26-20351.7%
Jun 26-20351.7%
Jun 26-20351.7%
Jun 26-20351.7%
Jun 26-20351.7%
May 26-20351.7%
May 26-20351.7%
May 26-20351.7%
May 26-20351.7%
May 26-20351.7%
Apr 26-20351.7%
Apr 26-20351.7%
Apr 26-20351.7%
Apr 26-20351.7%
Mar 26-20351.7%
Mar 26-20351.7%
Mar 26-20351.7%
Mar 26-20351.7%
Feb 26-20351.7%
Feb 26-20351.7%
Feb 26-20351.7%
Feb 26-20351.7%
Jan 26-20351.7%
Jan 26-20351.7%
Jan 26-20351.7%
Jan 26-20351.7%
Jan 26-20351.7%
Dec 25-20351.7%
Dec 25-20351.7%
Dec 25-20351.7%
Dec 25-20351.7%
Nov 25-20351.7%
Nov 25-20351.7%
Nov 25-20351.7%
Nov 25-20351.7%
Oct 25-20351.7%
Oct 25-20351.7%
Oct 25-20351.7%
Oct 25-20351.7%
Oct 25-20351.7%
Sep 25-20351.7%
Sep 25-20351.7%
Sep 25-20351.7%
Sep 25-20351.7%
Aug 25-20351.7%
Aug 25-20351.7%
Aug 25-20351.7%
Aug 25-20351.7%
Aug 25-20351.7%
Jul 25-20351.7%
Jul 25-20351.7%
Jul 25-20351.7%
Jul 25-20351.7%
Jun 25-20351.7%
Jun 25-20351.7%
Jun 25-20351.7%
Jun 25-20351.7%
May 25-20351.7%
May 25-20351.7%
May 25-20351.7%
May 25-20351.7%
May 25-20351.7%
Apr 25-20351.7%
Apr 25-20351.7%
Apr 25-20351.7%
Apr 25-20351.7%
Mar 25-20351.7%
Mar 25-20351.7%
Mar 25-20351.7%
Mar 25-20351.7%
Feb 25-20351.7%
Feb 25-20351.7%
Feb 25-20351.7%
Feb 25-20351.7%
Jan 25-20351.7%
Jan 25-20351.7%
Jan 25-20351.7%
Jan 25-20351.7%
Jan 25-20351.7%
Dec 24-20351.7%
Dec 24-20351.7%
Dec 24-20351.7%
Dec 24-20351.7%
Nov 24-20351.7%
Nov 24-20351.7%
Nov 24-20351.7%
Nov 24-20351.7%
Nov 24-20351.7%
Oct 24-20351.7%
Oct 24-20351.7%
Price to Sales
00.250.50.7511.25med 0Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
ADLI Price to Sales by quarter
PeriodPrice to Sales
Sep 260
Sep 260
Aug 260
Aug 260
Aug 260
Aug 260
Jul 260
Jul 260
Jul 260
Jul 260
Jul 260
Jun 260
Jun 260
Jun 260
Jun 260
May 260
May 260
May 260
May 260
May 260
Apr 260
Apr 260
Apr 260
Apr 260
Mar 260
Mar 260
Mar 260
Mar 260
Feb 260
Feb 260
Feb 260
Feb 260
Jan 260
Jan 260
Jan 260
Jan 260
Jan 260
Dec 250
Dec 250
Dec 250
Dec 250
Nov 250
Nov 250
Nov 250
Nov 250
Oct 250
Oct 250
Oct 250
Oct 250
Oct 250
Sep 250
Sep 250
Sep 250
Sep 250
Aug 250
Aug 250
Aug 250
Aug 250
Aug 250
Jul 250
Jul 250
Jul 250
Jul 250
Jun 250
Jun 250
Jun 250
Jun 250
May 250
May 250
May 250
May 250
May 250
Apr 250
Apr 250
Apr 250
Apr 250
Mar 250
Mar 250
Mar 250
Mar 250
Feb 250
Feb 250
Feb 250
Feb 250
Jan 250
Jan 250
Jan 250
Jan 250
Jan 250
Dec 240
Dec 240
Dec 240
Dec 240
Nov 240
Nov 240
Nov 240
Nov 240
Nov 240
Oct 240
Oct 240
EV/EBITDA
020406080med 7.97May 99Aug 99Dec 99Mar 00Jun 00Dec 00Mar 01
ADLI EV/EBITDA by quarter
PeriodEV/EBITDA
Mar 0117
Mar 0117.39
Mar 0112.56
Mar 0111.3
Mar 0113.72
Feb 0114.3
Feb 0114.98
Feb 0117.39
Feb 0117.68
Jan 0116.71
Jan 0116.71
Jan 0118.55
Jan 0119.8
Dec 0017.68
Dec 0061.93
Dec 0053.51
Dec 0051.48
Dec 0047.1
Nov 0050.14
Nov 0052.49
Nov 0051.48
Nov 0049.13
Oct 0049.13
Oct 0048.12
Oct 0060.92
Oct 0059.91
Sep 0055.53
Jun 0014.35
Jun 0016.21
Jun 0016.8
Jun 0012.78
May 0014.35
May 0014.35
May 0015.62
May 0016.8
Apr 0017.39
Apr 0016.8
Apr 0017.09
Apr 0020.82
Mar 0021.7
Mar 007.64
Mar 008.05
Mar 009.18
Mar 008.58
Feb 009.7
Feb 009.62
Feb 008.24
Feb 007.72
Jan 007.56
Jan 007.89
Jan 007.56
Jan 006.51
Dec 995.82
Dec 993.65
Dec 993.76
Dec 993.65
Dec 993.65
Nov 993.52
Nov 993.52
Nov 994.36
Nov 994.84
Oct 995.14
Oct 994.95
Oct 995.09
Oct 995.01
Oct 995.32
Sep 994.35
Sep 994.39
Sep 994.43
Sep 994.43
Aug 994.9
Aug 994.47
Aug 995.06
Aug 995.24
Jul 995.74
Jul 995.58
Jul 995.58
Jul 995.74
Jul 995.74
Jun 995.96
Jun 995.7
Jun 995.7
Jun 995.88
May 995.53
May 996.04
May 995.53
May 995.7
Apr 995.88
Apr 996.04
Apr 996.09
Apr 996.13
Apr 996.22
Price/Operating Cashflow
02.557.51012.5med 4.98Jul 00Oct 00Feb 01May 01Aug 01Dec 01Mar 02
ADLI Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Mar 026.25
Mar 026.03
Mar 026.91
Mar 026.14
Mar 027.02
Feb 027.13
Feb 026.58
Feb 026.8
Feb 027.9
Jan 029.43
Jan 028.22
Jan 0210.42
Jan 0210.1
Dec 013.09
Dec 011.69
Dec 012.29
Dec 012.58
Nov 012.63
Nov 012.6
Nov 012.86
Nov 012.86
Nov 013.18
Oct 013.55
Oct 013.43
Oct 012.43
Oct 011.77
Sep 011.63
Sep 011.47
Sep 011.83
Sep 011.57
Aug 011.91
Aug 012.22
Aug 012.1
Aug 012.2
Aug 012.88
Jul 013.03
Jul 013.22
Jul 013.53
Jul 013.43
Jun 013.92
Jun 017.92
Jun 018.13
Jun 018.41
Jun 018.13
May 018.13
May 018.13
May 018.13
May 018.13
Apr 018.68
Apr 016.83
Apr 018.62
Apr 018.46
Mar 015.18
Mar 015.32
Mar 013.68
Mar 013.26
Mar 014.08
Feb 014.27
Feb 014.5
Feb 015.32
Feb 015.41
Jan 015.09
Jan 015.09
Jan 015.71
Jan 016.13
Dec 005.41
Dec 0010.24
Dec 008.46
Dec 008.03
Dec 007.11
Nov 007.75
Nov 008.25
Nov 008.03
Nov 007.54
Oct 007.54
Oct 007.32
Oct 0010.02
Oct 009.81
Sep 008.89
Sep 004.78
Sep 004.98
Sep 004.98
Sep 004.78
Aug 004.78
Aug 004.98
Aug 004.33
Aug 004.64
Jul 004.78
Jul 004.98
Jul 005.19
Jul 004.33
Jun 004.33
Jun 004.01
Jun 004.62
Jun 004.81
Jun 003.5
May 004.01
May 004.01
May 004.43
May 004.81
Price to Book
0246med 1.39Oct 04Jan 05Apr 05Aug 05Nov 05Mar 06Jun 06
ADLI Price to Book by quarter
PeriodPrice to Book
Jun 064.47
Jun 064.12
Jun 064.47
Jun 064.64
May 064.81
May 064.64
May 063.95
May 063.95
Apr 063.94
Apr 063.94
Apr 063.63
Apr 063.44
Mar 063.44
Mar 061.52
Mar 061.32
Mar 061.06
Mar 061.06
Feb 061.26
Feb 061.26
Feb 061.12
Feb 061.12
Jan 061.12
Jan 061.12
Jan 061.06
Jan 061.32
Dec 051.09
Dec 051.15
Dec 051.43
Dec 051.44
Dec 051.44
Nov 051.5
Nov 051.39
Nov 051.5
Nov 051.65
Oct 051.39
Oct 051.44
Oct 051.56
Oct 051.67
Sep 051.73
Sep 051.36
Sep 051.46
Sep 051.41
Sep 051.41
Aug 051.41
Aug 051.5
Aug 051.5
Aug 051.5
Jul 051.46
Jul 051.64
Jul 051.64
Jul 051.68
Jul 051.71
Jun 051.44
Jun 051.44
Jun 051.48
Jun 051.52
May 051.44
May 051.52
May 051.29
May 051.29
Apr 051.82
Apr 051.71
Apr 051.71
Apr 051.71
Apr 051.63
Mar 051.28
Mar 051.28
Mar 051.13
Mar 051.25
Feb 051.1
Feb 051.13
Feb 051.16
Feb 051.16
Jan 051.16
Jan 051.35
Jan 051.41
Jan 051.41
Dec 041.38
Dec 041.28
Dec 040.99
Dec 041.12
Dec 040.96
Nov 041.12
Nov 040.86
Nov 040.96
Nov 040.89
Oct 040.86
Oct 040.86
Oct 040.96
Oct 040.96
Oct 041.05
Sep 040.72
Sep 040.91
Sep 041.24
Sep 041.32
Aug 041.01
Aug 041.01
Aug 041.16
Aug 041.16
Jul 041.29
American Medical Technologies Inc.
ADLI
Stockpicker

Video analysis: ADLI

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.